CSS LLC/IL - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$724,000
+42.8%
17,900
+103.4%
0.04%
+79.2%
Q2 2015$507,000
-70.1%
8,800
-66.9%
0.02%
-72.1%
Q1 2015$1,695,000
-46.1%
26,624
-47.7%
0.09%
-44.9%
Q4 2014$3,142,000
+59.0%
50,9000.0%0.16%
+62.5%
Q3 2014$1,976,000
-5.8%
50,900
-16.4%
0.10%
+10.3%
Q2 2014$2,097,000
+35.2%
60,900
+69.6%
0.09%
+11.5%
Q1 2014$1,551,00035,9000.08%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
BB BIOTECH AG 6,634,838$268,180,0008.50%
DOWLING & YAHNKE LLC 676,379$27,339,0003.72%
WILLIAM HARRIS INVESTORS INC 317,301$12,826,0003.63%
Opus Point Partners Management, LLC 101,401$4,099,0002.26%
SOUND ENERGY PARTNERS, INC. 25,000$1,011,0002.04%
Sonora Investment Management, LLC 127,104$6,622,0002.00%
PINNACLE ASSOCIATES LTD 1,778,325$71,880,0001.59%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 17,000$687,0001.36%
Apex Capital Management 1,019,618$41,213,0000.93%
PERKINS CAPITAL MANAGEMENT INC 20,350$823,0000.92%
View complete list of ISIS PHARMACEUTICALS INC shareholders